BR0001794A - Aplicação de fitosteróides (e seus isÈmeros), ácidofólico, cianocobalamina e piridoxina em fibrasdietéticas (alimentares) - Google Patents

Aplicação de fitosteróides (e seus isÈmeros), ácidofólico, cianocobalamina e piridoxina em fibrasdietéticas (alimentares)

Info

Publication number
BR0001794A
BR0001794A BR0001794-9A BR0001794A BR0001794A BR 0001794 A BR0001794 A BR 0001794A BR 0001794 A BR0001794 A BR 0001794A BR 0001794 A BR0001794 A BR 0001794A
Authority
BR
Brazil
Prior art keywords
phytosteroids
pyridoxine
isomers
food
application
Prior art date
Application number
BR0001794-9A
Other languages
English (en)
Inventor
Roberto Luiz Bruno Penteado
Marcio Falci
Original Assignee
Laboratorios Biosintetica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Biosintetica Ltda filed Critical Laboratorios Biosintetica Ltda
Priority to BR0001794-9A priority Critical patent/BR0001794A/pt
Priority to US09/854,859 priority patent/US20020018811A1/en
Priority to CO01038341A priority patent/CO5280197A1/es
Priority to MXPA01004885A priority patent/MXPA01004885A/es
Priority to EP01111751A priority patent/EP1155699A1/en
Publication of BR0001794A publication Critical patent/BR0001794A/pt
Priority to US10/165,896 priority patent/US7147859B2/en
Priority to US10/959,603 priority patent/US20060039932A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"APLICAçãO DE FITOSTERóIDES (E SEUS ISÈMEROS) áCIDOFóLICO, CIANOCOBALAMINA E PIRIDOXINA EM FIBRASDIETéTICAS (ALIMENTARES)". Trata-se de uma ASSOCIAçãOde agentes químicos com a precípua intenção de açãofarmacológica para se evitar o risco de enfarto e acidente vascularcerebral decorrentes do desenvolvimento do processoaterosclerótico e da homocisteinemia decorrente da idade. é deextrema importância a atuação no sentido de evitar o aumento daHomocisteína endógena. A homocisteína em níveis elevados nosangue, decorrente de erro genético e demais circuntânciasbiológicas proporciona consequências danosas ao organismohumano (oclusão de artérias, alterações oculares, osteoporose,sistema nervoso).
BR0001794-9A 2000-05-15 2000-05-15 Aplicação de fitosteróides (e seus isÈmeros), ácidofólico, cianocobalamina e piridoxina em fibrasdietéticas (alimentares) BR0001794A (pt)

Priority Applications (7)

Application Number Priority Date Filing Date Title
BR0001794-9A BR0001794A (pt) 2000-05-15 2000-05-15 Aplicação de fitosteróides (e seus isÈmeros), ácidofólico, cianocobalamina e piridoxina em fibrasdietéticas (alimentares)
US09/854,859 US20020018811A1 (en) 2000-05-15 2001-05-14 Application of phytosteroids(and isomers thereof), folic acid, cyanocobalamine and pyridoxine in dietetic (alimentary) fibers
CO01038341A CO5280197A1 (es) 2000-05-15 2001-05-15 Aplicvacion de fitoesteroides (e isomeros de estos), acido folico, cianocobalamina piridoxina en fibras dieteticas (alimenticias)
MXPA01004885A MXPA01004885A (es) 2000-05-15 2001-05-15 Aplicacion de fitoesteroides (e isomeros de los mismos), acido folico, cianocobalamina y piridoxina en fibras dieteticas (alimenticias).
EP01111751A EP1155699A1 (en) 2000-05-15 2001-05-15 Pharmaceutical and nutritional compositions comprising phytosterols, folic acid, cyanocobalamine, pyridoxine and alimentary fibers
US10/165,896 US7147859B2 (en) 2000-05-15 2002-06-10 Application of phytosterols (and their isomers), folic acid, cyanocobalamin and pyridoxin in dietetic (alimentary) fibers
US10/959,603 US20060039932A1 (en) 2000-05-15 2004-10-06 Application of phytosteroids (and isomers thereof), folic acid, cyanocobalamine and pyridoxine in dietetic (alimentary) fibers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0001794-9A BR0001794A (pt) 2000-05-15 2000-05-15 Aplicação de fitosteróides (e seus isÈmeros), ácidofólico, cianocobalamina e piridoxina em fibrasdietéticas (alimentares)

Publications (1)

Publication Number Publication Date
BR0001794A true BR0001794A (pt) 2001-12-26

Family

ID=3944162

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0001794-9A BR0001794A (pt) 2000-05-15 2000-05-15 Aplicação de fitosteróides (e seus isÈmeros), ácidofólico, cianocobalamina e piridoxina em fibrasdietéticas (alimentares)

Country Status (5)

Country Link
US (2) US20020018811A1 (pt)
EP (1) EP1155699A1 (pt)
BR (1) BR0001794A (pt)
CO (1) CO5280197A1 (pt)
MX (1) MXPA01004885A (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
US6867183B2 (en) * 2001-02-15 2005-03-15 Nobex Corporation Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US6770625B2 (en) 2001-09-07 2004-08-03 Nobex Corporation Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
US7196059B2 (en) * 2001-09-07 2007-03-27 Biocon Limited Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7030082B2 (en) * 2001-09-07 2006-04-18 Nobex Corporation Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
CA2498957A1 (en) * 2002-10-31 2004-05-13 Unilever Plc Water in oil emulsion comprising sterolesters
GB0329667D0 (en) * 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
GB0513881D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
US20080182801A1 (en) * 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
EP1732605B1 (en) 2004-03-29 2019-05-08 Wyeth LLC Multi-vitamin and mineral nutritional supplements
US20060135610A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Cardiovascular compositions
GB0512726D0 (en) * 2005-06-22 2005-07-27 Btg Int Ltd Multiple sclerosis therapy and diagnosis
GB0513888D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
GB0513883D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Diagnosis of Atherosclerosis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5132113A (en) * 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids
US5795873A (en) * 1992-12-29 1998-08-18 Metabolite Laboratories, Inc. Method for treatment and prevention of deficiencies of vitamins B12, folic acid and B6
US5700782A (en) * 1993-05-28 1997-12-23 Abbott Laboratories Enteral nutritional product
WO1995000158A1 (en) * 1993-06-25 1995-01-05 Bio-Sphere Technology Dietary supplement incorporating beta-sitosterol and pectin
ES2464465T3 (es) * 1994-09-29 2014-06-02 Pharmachem Laboratories, Inc. Composiciones de esteroles a partir de jabón de pulpa
CA2280093A1 (en) * 1997-02-04 1998-08-06 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
US5929062A (en) * 1997-06-19 1999-07-27 University Of Western Ontario Oxysterol inhibition of dietary cholesterol uptake
US5770217A (en) * 1997-07-02 1998-06-23 Atlatl, Inc. Dietary supplement for hematological, immune and appetite enhancement
AU9209898A (en) * 1997-09-02 1999-03-22 Ricex Company, Inc., The A method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis
DE19750453A1 (de) * 1997-11-14 1999-05-27 Henkel Kgaa Verwendung von Wirkstoffmischungen zur Herstellung von hypocholesterinämischen Mitteln
US5932562A (en) * 1998-05-26 1999-08-03 Washington University Sitostanol formulation to reduce cholesterol absorption and method for preparing and use of same
WO1999065337A1 (en) * 1998-06-19 1999-12-23 Beth Israel Deaconess Medical Center Dietary supplement for post-menopausal women

Also Published As

Publication number Publication date
EP1155699A1 (en) 2001-11-21
US20020018811A1 (en) 2002-02-14
CO5280197A1 (es) 2003-05-30
MXPA01004885A (es) 2004-11-10
US20060039932A1 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
BR0001794A (pt) Aplicação de fitosteróides (e seus isÈmeros), ácidofólico, cianocobalamina e piridoxina em fibrasdietéticas (alimentares)
Regland et al. Homocysteinemia is a common feature of schizophrenia
BR9811825A (pt) Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue
BR9915553A (pt) Amidas de ácido antranìlico e seu emprego como medicamento
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
BRPI0414435A (pt) métodos e reagentes para o tratamento de distúrbios imunoinflamatórios
BRPI0414215A (pt) tienopirazóis
NO20020056D0 (no) Fremgangsmåte og system for anvendelse ved behandling av en pasient med et hvilket som helst medikament for å optimalisereterapien og forhindre en negativ medikamentrespons
Moriatis et al. Limb swelling in patients who have fibrodysplasia ossificans progressiva
Baggott et al. Urinary adenosine and aminoimidazolecarboxamide excretion in methotrexate-treated patients with psoriasis
Patel et al. Increased oxidative capacity does not protect skeletal muscle fibers from eccentric contraction-induced injury
BR9808008A (pt) Processo para o tratamento anticoagulante e/ou antitrombótico de um ser humano ou outro paciente animal de sangue quente, usos de um oligossacarìdeo sulfatado e na fabricação de um medicamento, e, composição farmacêutica ou veterinária para tratamento anticoagulante e/ou antitrombótico.
BR0309595A (pt) Injeção produzida a partir de ixeris sonchifolia hance para o tratamento de doenças vasculares cardiocerebrais e doenças de fundo, e método para a produção da mesma
BR0006076A (pt) Composição contento carnitina e fosfato de inositol útil como suplemento dietético ou medicamento
Hansen et al. Total body protein in chronic diseases and in aging
ZIMMERMAN et al. Serum Enzymes in Disease: II. Lactic Dehydrogenase and Glutamic Oxalacetic Transaminase in Anemia
KR930702995A (ko) 세포증식 매트릭스 및 그 용도
SE8500996D0 (sv) Method of treatment
BR0308415A (pt) Métodos de tratamento de diabetes usando-se inibidores de pde11a
BR0113372A (pt) Composição farmacêutica com carreador modificado, método de fabricação da mesma e seus usos
Huang Neuroleptic malignant syndrome associated with long-term clozapine treatment: report of a case and results of a clozapine rechallenge
DK0821593T3 (da) Konjugat af et aktivt middel, et protein og eventuelt et for kroppen ikke som fremmed anset nativt protein
Goldenberg et al. Gabapentin for disruptive behaviour in an elderly demented patient.
BR9608147A (pt) Método para descontaminação microbiana de plaquetas sanguìneas.
BR0011049A (pt) Fenilciclohexanocarboxamidas substituìdas e seu uso como inibidores de absorção de adenosina

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: BIOSINTETICA FARMACEUTICA LTDA (BR/SP)

Free format text: ALTERADO DE: LABORATORIOS BIOSINTETICA LTDA

B25G Requested change of headquarter approved

Owner name: BIOSINTETICA FARMACEUTICA LTDA (BR/SP)

Free format text: ALTERADA A SEDE DO TITULAR CONFORME REQUERIDO NA PETICAO NO 018050004541/SP DE 18/07/2005.

B25M Entry on limitation or onus of patent assignment [chapter 25.13 patent gazette]

Owner name: BIOSINTETICA FARMACEUTICA LTDA (BR/SP)

Free format text: REF: PROC. INPI NO 52400031036/2012-78 E PROCESSO DE ARROLAMENTO DE BENS DA SECRETARIA DA RECEITA FEDERAL SP NO 16643.720002/2011-54 ANOTADO O ARROLAMENTO DO PEDIDO DE PATENTE EM EPIGRAFE, CONFORME DETERMINACAO DA SECRETARIA DA RECEITA FEDERAL DO ESTADO DE SAO PAULO, NOS TERMOS DO 5O, DO ART. 64 DA LEI NO 9.532/97.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: A61K 35/78

Ipc: A61K 31/56 (2006.01), A61K 31/575 (2006.01), A61K

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 13, 24 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]